Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):739–743. doi: 10.1111/j.1476-5381.1992.tb09048.x

Effect of K+ channel-modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea-pig isolated perfused heart.

J D McLeod 1, P J Piper 1
PMCID: PMC1908434  PMID: 1378344

Abstract

1. The vascular actions of leukotrienes C4 (LTC4) and LTD4 in the guinea-pig isolated perfused heart were studied in the presence of potassium (K+) channel modulatory compounds. 2. Cromakalim (0.35-10 microM), a K+ channel activator, inhibited the vasoconstrictor responses of LTC4 (30 pmol), LTD4 (30 pmol) and angiotensin II (AII) (100 pmol) in a concentration-dependent manner. 3. Glyceryl trinitrate (10 mgl-1) and vasoactive intestinal peptide (10 nM) induced a similar vasodilator action to cromakalim in the isolated heart but had no effect on responses to LTC4 and LTD4. 4. The inhibitory action by cromakalim (10 microM) on the LTC4 (30 pmol) response could be reversed in the presence of an equimolar concentration of glibenclamide. However, glibenclamide (10 microM) only partially restored the LTD4 (30 pmol) actions. 5. Galanin (10 nM) and charybdotoxin (60 nM) had no effect on the vascular responses to LTC4 and LTD4 (30 pmol). 6. Inhibition by cromakalim of coronary vasospasm induced by vascular LTC4, LTD4 and AII appears to be separate from its vasodilator action and it is postulated that a cromakalim-sensitive mechanism in the coronary vasculature is important in the vasoconstrictor responses to LTC4, LTD4 and AII.

Full text

PDF
739

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrén B., Rorsman P., Berggren P. O. Galanin and the endocrine pancreas. FEBS Lett. 1988 Mar 14;229(2):233–237. doi: 10.1016/0014-5793(88)81131-1. [DOI] [PubMed] [Google Scholar]
  2. Beech D. J., Bolton T. B. Properties of the cromakalim-induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein. Br J Pharmacol. 1989 Nov;98(3):851–864. doi: 10.1111/j.1476-5381.1989.tb14614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bray K. M., Newgreen D. T., Small R. C., Southerton J. S., Taylor S. G., Weir S. W., Weston A. H. Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate. Br J Pharmacol. 1987 Jun;91(2):421–429. doi: 10.1111/j.1476-5381.1987.tb10297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bray K. M., Weston A. H., Duty S., Newgreen D. T., Longmore J., Edwards G., Brown T. J. Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta. Br J Pharmacol. 1991 Feb;102(2):337–344. doi: 10.1111/j.1476-5381.1991.tb12175.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burke J. A., Levi R., Guo Z. G., Corey E. J. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther. 1982 Apr;221(1):235–241. [PubMed] [Google Scholar]
  6. Carmeliet E. K+ channels in cardiac cells: mechanisms of activation, inactivation, rectification and K+e sensitivity. Pflugers Arch. 1989;414 (Suppl 1):S88–S92. doi: 10.1007/BF00582254. [DOI] [PubMed] [Google Scholar]
  7. Cocks T. M., King S. J., Angus J. A. Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro. Br J Pharmacol. 1990 Jun;100(2):375–378. doi: 10.1111/j.1476-5381.1990.tb15812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cook D. L., Hales C. N. Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature. 1984 Sep 20;311(5983):271–273. doi: 10.1038/311271a0. [DOI] [PubMed] [Google Scholar]
  9. Cook N. S., Weir S. W., Danzeisen M. C. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine. Br J Pharmacol. 1988 Nov;95(3):741–752. doi: 10.1111/j.1476-5381.1988.tb11700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Daut J., Maier-Rudolph W., von Beckerath N., Mehrke G., Günther K., Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science. 1990 Mar 16;247(4948):1341–1344. doi: 10.1126/science.2107575. [DOI] [PubMed] [Google Scholar]
  11. Davies N. W. Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular protons. Nature. 1990 Jan 25;343(6256):375–377. doi: 10.1038/343375a0. [DOI] [PubMed] [Google Scholar]
  12. Dunne M. J., Bullett M. J., Li G. D., Wollheim C. B., Petersen O. H. Galanin activates nucleotide-dependent K+ channels in insulin-secreting cells via a pertussis toxin-sensitive G-protein. EMBO J. 1989 Feb;8(2):413–420. doi: 10.1002/j.1460-2075.1989.tb03392.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ganz P., Alexander R. W. New insights into the cellular mechanisms of vasospasm. Am J Cardiol. 1985 Sep 18;56(9):11E–15E. doi: 10.1016/0002-9149(85)91170-1. [DOI] [PubMed] [Google Scholar]
  14. Gelband C. H., Lodge N. J., Van Breemen C. A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim. Eur J Pharmacol. 1989 Aug 22;167(2):201–210. doi: 10.1016/0014-2999(89)90580-3. [DOI] [PubMed] [Google Scholar]
  15. Giudicelli J. F., la Rochelle C. D., Berdeaux A. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs. J Pharmacol Exp Ther. 1990 Nov;255(2):836–842. [PubMed] [Google Scholar]
  16. Grover G. J., Dzwonczyk S., Sleph P. G. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891. Eur J Pharmacol. 1990 Nov 20;191(1):11–18. doi: 10.1016/0014-2999(90)94091-b. [DOI] [PubMed] [Google Scholar]
  17. Jones T. R., Charette L., Garcia M. L., Kaczorowski G. J. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor. J Pharmacol Exp Ther. 1990 Nov;255(2):697–706. [PubMed] [Google Scholar]
  18. Jose P., Niederhauser U., Piper P. J., Robinson C., Smith A. P. Degradation of porstaglandin F2alpha in the human pulmonary circulation. Thorax. 1976 Dec;31(6):713–719. doi: 10.1136/thx.31.6.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kim S., Morimoto S., Koh E., Miyashita Y., Ogihara T. Comparison of effects of a potassium channel opener BRL34915, a specific potassium ionophore valinomycin and calcium channel blockers on endothelin-induced vascular contraction. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1003–1008. doi: 10.1016/0006-291x(89)91769-5. [DOI] [PubMed] [Google Scholar]
  20. Lefer A. M., Yanagisawa A. Inhibition of leukotriene actions by the calcium channel blocker, nisoldipine. Proc Soc Exp Biol Med. 1986 Jul;182(3):296–300. doi: 10.3181/00379727-182-42342. [DOI] [PubMed] [Google Scholar]
  21. Marone G., Giordano A., Cirillo R., Triggiani M., Vigorito C. Cardiovascular and metabolic effects of peptide leukotrienes in man. Ann N Y Acad Sci. 1988;524:321–333. doi: 10.1111/j.1749-6632.1988.tb38555.x. [DOI] [PubMed] [Google Scholar]
  22. Masuzawa K., Matsuda T., Asano M. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery. Br J Pharmacol. 1990 May;100(1):143–149. doi: 10.1111/j.1476-5381.1990.tb12066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McLeod J. D., Piper P. J. Effect of ICI 198,615, SK+F 104,353, MK-571 and CGP45715A on cysteinyl leukotriene-induced responses in guinea-pig heart. Prostaglandins. 1991 Apr;41(4):395–406. doi: 10.1016/0090-6980(91)90008-4. [DOI] [PubMed] [Google Scholar]
  24. McPherson G. A., Angus J. A. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol. 1990 Jun;100(2):201–206. doi: 10.1111/j.1476-5381.1990.tb15782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nakayama K., Watanabe N., Yamazawa T., Takeshita N., Tanaka Y., Yanaihara N. Effects of porcine galanin on the mesenteric microcirculation and arteriolar smooth muscle in the rat. Eur J Pharmacol. 1991 Jan 25;193(1):75–80. doi: 10.1016/0014-2999(91)90202-2. [DOI] [PubMed] [Google Scholar]
  26. Nelson M. T., Patlak J. B., Worley J. F., Standen N. B. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol. 1990 Jul;259(1 Pt 1):C3–18. doi: 10.1152/ajpcell.1990.259.1.C3. [DOI] [PubMed] [Google Scholar]
  27. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983 Sep 8;305(5930):147–148. doi: 10.1038/305147a0. [DOI] [PubMed] [Google Scholar]
  28. Okabe K., Kajioka S., Nakao K., Kitamura K., Kuriyama H., Weston A. H. Actions of cromakalim on ionic currents recorded from single smooth muscle cells of the rat portal vein. J Pharmacol Exp Ther. 1990 Feb;252(2):832–839. [PubMed] [Google Scholar]
  29. Quast U., Cook N. S. Moving together: K+ channel openers and ATP-sensitive K+ channels. Trends Pharmacol Sci. 1989 Nov;10(11):431–435. doi: 10.1016/S0165-6147(89)80003-3. [DOI] [PubMed] [Google Scholar]
  30. Radomski M. W., Palmer R. M., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987 Nov;92(3):639–646. doi: 10.1111/j.1476-5381.1987.tb11367.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Spruce A. E., Standen N. B., Stanfield P. R. Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane. Nature. 1985 Aug 22;316(6030):736–738. doi: 10.1038/316736a0. [DOI] [PubMed] [Google Scholar]
  32. Standen N. B., Quayle J. M., Davies N. W., Brayden J. E., Huang Y., Nelson M. T. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989 Jul 14;245(4914):177–180. doi: 10.1126/science.2501869. [DOI] [PubMed] [Google Scholar]
  33. Sturgess N. C., Ashford M. L., Cook D. L., Hales C. N. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet. 1985 Aug 31;2(8453):474–475. doi: 10.1016/s0140-6736(85)90403-9. [DOI] [PubMed] [Google Scholar]
  34. Vázquez J., Feigenbaum P., Katz G., King V. F., Reuben J. P., Roy-Contancin L., Slaughter R. S., Kaczorowski G. J., Garcia M. L. Characterization of high affinity binding sites for charybdotoxin in sarcolemmal membranes from bovine aortic smooth muscle. Evidence for a direct association with the high conductance calcium-activated potassium channel. J Biol Chem. 1989 Dec 15;264(35):20902–20909. [PubMed] [Google Scholar]
  35. de Weille J., Schmid-Antomarchi H., Fosset M., Lazdunski M. ATP-sensitive K+ channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1312–1316. doi: 10.1073/pnas.85.4.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES